Pharmaron

Pharmaron, established in 2004, is a premier global provider of integrated drug discovery, development, and manufacturing services. Operating within the Business Services sector, the company specializes in small molecule drugs, cell therapies, and gene therapies, alongside comprehensive testing services for medical devices and clinical research. Its extensive service portfolio encompasses laboratory operations, clinical development, and chemistry, manufacturing, and controls (CMC), supporting clients from early-stage research through to commercialization. Pharmaron's commitment to scientific excellence and problem-solving positions it as a key partner in the life science industry, facilitating regulatory approvals and market entry for innovative therapeutics.

With a substantial global footprint, Pharmaron employs over 10,000 professionals across 12 operational locations worldwide. This extensive workforce and geographic presence enable the company to offer end-to-end solutions and robust bioanalytical support. The organization fosters a culture of talent development and continuous learning, ensuring its teams are equipped with the expertise required for complex R&D challenges. For insights into the people driving Pharmaron's innovation, consider Meet Pharmaron's team. The company's operational scale and integrated service model are designed to accelerate client projects efficiently and effectively.

Financially, Pharmaron reported a significant revenue of $1.8 billion. The company has a history of strategic funding, including Series C and Series B rounds, and a substantial unspecified funding round, indicating strong investor confidence in its growth trajectory and market position. This financial backing supports its ongoing expansion and investment in cutting-edge technologies. To delve deeper into the company's financial performance and metrics, please Explore financial highlights. Pharmaron's strategic investments and revenueView more...